Endothelial Progenitor Cells and Rheumatoid Arthritis : Response to Endothelial Dysfunction and Clinical Evidences
Rheumatoid Arthritis (RA) is a chronic autoimmune inflammatory disease characterized by the swelling of multiple joints, pain and stiffness, and accelerated atherosclerosis. Sustained immune response and chronic inflammation, which characterize RA, may induce endothelial activation, damage and dysfunction. An equilibrium between endothelial damage and repair, together with the preservation of endothelial integrity, is of crucial importance for the homeostasis of endothelium. Endothelial Progenitor Cells (EPCs) represent a heterogenous cell population, characterized by the ability to differentiate into mature endothelial cells (ECs), which contribute to vascular homeostasis, neovascularization and endothelial repair. A modification of the number and function of EPCs has been described in numerous chronic inflammatory and auto-immune conditions; however, reports that focus on the number and functions of EPCs in RA are characterized by conflicting results, and discrepancies exist among different studies. In the present review, the authors describe EPCs' role and response to RA-related endothelial modification, with the aim of illustrating current evidence regarding the level of EPCs and their function in this disease, to summarize EPCs' role as a biomarker in cardiovascular comorbidities related to RA, and finally, to discuss the modulation of EPCs secondary to RA therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
International journal of molecular sciences - 22(2021), 24 vom: 20. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Komici, Klara [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Completed 28.01.2022 Date Revised 28.01.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms222413675 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM334843766 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM334843766 | ||
003 | DE-627 | ||
005 | 20231225224553.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms222413675 |2 doi | |
028 | 5 | 2 | |a pubmed24n1116.xml |
035 | |a (DE-627)NLM334843766 | ||
035 | |a (NLM)34948469 | ||
035 | |a (PII)13675 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Komici, Klara |e verfasserin |4 aut | |
245 | 1 | 0 | |a Endothelial Progenitor Cells and Rheumatoid Arthritis |b Response to Endothelial Dysfunction and Clinical Evidences |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.01.2022 | ||
500 | |a Date Revised 28.01.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Rheumatoid Arthritis (RA) is a chronic autoimmune inflammatory disease characterized by the swelling of multiple joints, pain and stiffness, and accelerated atherosclerosis. Sustained immune response and chronic inflammation, which characterize RA, may induce endothelial activation, damage and dysfunction. An equilibrium between endothelial damage and repair, together with the preservation of endothelial integrity, is of crucial importance for the homeostasis of endothelium. Endothelial Progenitor Cells (EPCs) represent a heterogenous cell population, characterized by the ability to differentiate into mature endothelial cells (ECs), which contribute to vascular homeostasis, neovascularization and endothelial repair. A modification of the number and function of EPCs has been described in numerous chronic inflammatory and auto-immune conditions; however, reports that focus on the number and functions of EPCs in RA are characterized by conflicting results, and discrepancies exist among different studies. In the present review, the authors describe EPCs' role and response to RA-related endothelial modification, with the aim of illustrating current evidence regarding the level of EPCs and their function in this disease, to summarize EPCs' role as a biomarker in cardiovascular comorbidities related to RA, and finally, to discuss the modulation of EPCs secondary to RA therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a endothelial colony forming cells | |
650 | 4 | |a endothelial dysfunction | |
650 | 4 | |a endothelial progenitor cells | |
650 | 4 | |a myeloid angiogenic cells | |
650 | 4 | |a rheumatoid arthritis | |
650 | 7 | |a Biomarkers |2 NLM | |
700 | 1 | |a Perna, Angelica |e verfasserin |4 aut | |
700 | 1 | |a Rocca, Aldo |e verfasserin |4 aut | |
700 | 1 | |a Bencivenga, Leonardo |e verfasserin |4 aut | |
700 | 1 | |a Rengo, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Guerra, Germano |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 22(2021), 24 vom: 20. Dez. |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2021 |g number:24 |g day:20 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms222413675 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2021 |e 24 |b 20 |c 12 |